Global Antibody Drug Conjugate Market Research Report 2019-2023

Published: May, 2019 | Pages: 163 | Publisher: 9Dimen Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Antibody Drug Conjugate Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Antibody Drug Conjugate market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023.

The report firstly introduced the Antibody Drug Conjugate basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. 

The major players profiled in this report include:

•	Seattle Genetics
•	Roche
•	ImmunoGen
•	Immunomedics
•	Pfizer
•	Celldex Therapeutics
•	Millennium Pharmaceuticals
•	Bayer HealthCare
•	Mersana Therapeutics
•	Heidelberg Pharma
•	Oxford BioTherapeutics
•	Takeda Pharmaceutical

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-

•	Adcetris
•	Kadcyl

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody Drug Conjugate for each application, including-

•	Hospital
•	Pharmaceutical Company
•	Research Institutions

 Table of Contents

Part I Antibody Drug Conjugate Industry Overview

Chapter One Antibody Drug Conjugate Industry Overview
1.1 Antibody Drug Conjugate Definition
1.2 Antibody Drug Conjugate Classification Analysis
1.2.1 Antibody Drug Conjugate Main Classification Analysis
1.2.2 Antibody Drug Conjugate Main Classification Share Analysis
1.3 Antibody Drug Conjugate Application Analysis
1.3.1 Antibody Drug Conjugate Main Application Analysis
1.3.2 Antibody Drug Conjugate Main Application Share Analysis
1.4 Antibody Drug Conjugate Industry Chain Structure Analysis
1.5 Antibody Drug Conjugate Industry Development Overview
1.5.1 Antibody Drug Conjugate Product History Development Overview
1.5.1 Antibody Drug Conjugate Product Market Development Overview
1.6 Antibody Drug Conjugate Global Market Comparison Analysis
1.6.1 Antibody Drug Conjugate Global Import Market Analysis
1.6.2 Antibody Drug Conjugate Global Export Market Analysis
1.6.3 Antibody Drug Conjugate Global Main Region Market Analysis
1.6.4 Antibody Drug Conjugate Global Market Comparison Analysis
1.6.5 Antibody Drug Conjugate Global Market Development Trend Analysis

Chapter Two Antibody Drug Conjugate Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis 
2.1.1 Proportion of Manufacturing Cost 
2.1.2 Manufacturing Cost Structure of Antibody Drug Conjugate Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Antibody Drug Conjugate Industry (The Report Company Including the Below Listed But Not All) 
 
Chapter Three Asia Antibody Drug Conjugate Market Analysis
3.1 Asia Antibody Drug Conjugate Product Development History
3.2 Asia Antibody Drug Conjugate Competitive Landscape Analysis
3.3 Asia Antibody Drug Conjugate Market Development Trend

Chapter Four 2014-2019 Asia Antibody Drug Conjugate Productions Supply Sales Demand Market Status and Forecast
4.1 2014-2019 Antibody Drug Conjugate Production Overview
4.2 2014-2019 Antibody Drug Conjugate Production Market Share Analysis
4.3 2014-2019 Antibody Drug Conjugate Demand Overview
4.4 2014-2019 Antibody Drug Conjugate Supply Demand and Shortage
4.5 2014-2019 Antibody Drug Conjugate Import Export Consumption
4.6 2014-2019 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Chapter Five Asia Antibody Drug Conjugate Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information

Chapter Six Asia Antibody Drug Conjugate Industry Development Trend
6.1 2019-2023 Antibody Drug Conjugate Production Overview
6.2 2019-2023 Antibody Drug Conjugate Production Market Share Analysis
6.3 2019-2023 Antibody Drug Conjugate Demand Overview
6.4 2019-2023 Antibody Drug Conjugate Supply Demand and Shortage
6.5 2019-2023 Antibody Drug Conjugate Import Export Consumption
6.6 2019-2023 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Part III North American Antibody Drug Conjugate Industry (The Report Company Including the Below Listed But Not All)
 
Chapter Seven North American Antibody Drug Conjugate Market Analysis
7.1 North American Antibody Drug Conjugate Product Development History
7.2 North American Antibody Drug Conjugate Competitive Landscape Analysis
7.3 North American Antibody Drug Conjugate Market Development Trend

Chapter Eight 2014-2019 North American Antibody Drug Conjugate Productions Supply Sales Demand Market Status and Forecast
8.1 2014-2019 Antibody Drug Conjugate Production Overview
8.2 2014-2019 Antibody Drug Conjugate Production Market Share Analysis
8.3 2014-2019 Antibody Drug Conjugate Demand Overview
8.4 2014-2019 Antibody Drug Conjugate Supply Demand and Shortage
8.5 2014-2019 Antibody Drug Conjugate Import Export Consumption
8.6 2014-2019 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Chapter Nine North American Antibody Drug Conjugate Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information

Chapter Ten North American Antibody Drug Conjugate Industry Development Trend
10.1 2019-2023 Antibody Drug Conjugate Production Overview
10.2 2019-2023 Antibody Drug Conjugate Production Market Share Analysis
10.3 2019-2023 Antibody Drug Conjugate Demand Overview
10.4 2019-2023 Antibody Drug Conjugate Supply Demand and Shortage
10.5 2019-2023 Antibody Drug Conjugate Import Export Consumption
10.6 2019-2023 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Part IV Europe Antibody Drug Conjugate Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Antibody Drug Conjugate Market Analysis
11.1 Europe Antibody Drug Conjugate Product Development History
11.2 Europe Antibody Drug Conjugate Competitive Landscape Analysis
11.3 Europe Antibody Drug Conjugate Market Development Trend

Chapter Twelve 2014-2019 Europe Antibody Drug Conjugate Productions Supply Sales Demand Market Status and Forecast
12.1 2014-2019 Antibody Drug Conjugate Production Overview
12.2 2014-2019 Antibody Drug Conjugate Production Market Share Analysis
12.3 2014-2019 Antibody Drug Conjugate Demand Overview
12.4 2014-2019 Antibody Drug Conjugate Supply Demand and Shortage
12.5 2014-2019 Antibody Drug Conjugate Import Export Consumption
12.6 2014-2019 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Chapter Thirteen Europe Antibody Drug Conjugate Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information

Chapter Fourteen Europe Antibody Drug Conjugate Industry Development Trend
14.1 2019-2023 Antibody Drug Conjugate Production Overview
14.2 2019-2023 Antibody Drug Conjugate Production Market Share Analysis
14.3 2019-2023 Antibody Drug Conjugate Demand Overview
14.4 2019-2023 Antibody Drug Conjugate Supply Demand and Shortage
14.5 2019-2023 Antibody Drug Conjugate Import Export Consumption
14.6 2019-2023 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Part V Antibody Drug Conjugate Marketing Channels and Investment Feasibility

Chapter Fifteen Antibody Drug Conjugate Marketing Channels Development Proposals Analysis
15.1 Antibody Drug Conjugate Marketing Channels Status
15.2 Antibody Drug Conjugate Marketing Channels Characteristic
15.3 Antibody Drug Conjugate Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Antibody Drug Conjugate New Project Investment Feasibility Analysis
17.1 Antibody Drug Conjugate Market Analysis
17.2 Antibody Drug Conjugate Project SWOT Analysis
17.3 Antibody Drug Conjugate New Project Investment Feasibility Analysis

Part VI Global Antibody Drug Conjugate Industry Conclusions

Chapter Eighteen 2014-2019 Global Antibody Drug Conjugate Productions Supply Sales Demand Market Status and Forecast
18.1 2014-2019 Antibody Drug Conjugate Production Overview
18.2 2014-2019 Antibody Drug Conjugate Production Market Share Analysis
18.3 2014-2019 Antibody Drug Conjugate Demand Overview
18.4 2014-2019 Antibody Drug Conjugate Supply Demand and Shortage
18.5 2014-2019 Antibody Drug Conjugate Import Export Consumption
18.6 2014-2019 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Chapter Nineteen Global Antibody Drug Conjugate Industry Development Trend
19.1 2019-2023 Antibody Drug Conjugate Production Overview
19.2 2019-2023 Antibody Drug Conjugate Production Market Share Analysis
19.3 2019-2023 Antibody Drug Conjugate Demand Overview
19.4 2019-2023 Antibody Drug Conjugate Supply Demand and Shortage
19.5 2019-2023 Antibody Drug Conjugate Import Export Consumption
19.6 2019-2023 Antibody Drug Conjugate Cost Price Production Value Gross Margin

Chapter Twenty Global Antibody Drug Conjugate Industry Research Conclusions